Safety evaluation of long-term intake of Fermented barley GABA 90 %. -Placebo-controlled, double-blind, randomized, parallel-group comparative study- - Safety evaluation of long-term intake of Fermented barley GABA 90 %. -Placebo-controlled, double-blind, randomized, parallel-group comparative study

Miura Clinic, Medical Corporation Kanonkai0 个研究点目标入组 48 人开始时间: 2022年3月18日最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•(1) Subjects with heart, liver, and kidney diseases (including complications of other diseases) (2) Subjects with a history of cardiovascular disease (3) Subjects with diabetes (4) Subjects with diseases currently being treated (5) Subjects who are allergic to food and drugs (6) Subjects with anemia symptoms (7) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects (8) Subjects who go to the hospital for some illness or are treated with drugs and Chinese medicine (temporary administration is possible) (9) Subjects who play intense sports and subjects who are on a diet (10) Subjects with extremely irregular eating habits (11) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (12) Subjects who drink more than 60 g of average daily pure alcohol (13) Subjects who smoke an average of 21 or more cigarettes a day (14) Subjects who are participating in or will participate in other clinical trials at the start of this study (15) Subjects who were vaccinated against infectious diseases such as influenza and COVID-19 within 1 month before SCR (16) Other subjects judged by the investigator or the investigator to be inappropriate for the examination

发起方

Miura Clinic, Medical Corporation Kanonkai